Alzheimer’s Drug

SAN DIEGO — Eli Lilly & Co. sued the University of California, San Diego, in Superior Court, claiming that UCSD diverted nearly $20 million of the $38 million that it provided for a clinical study of solanezumab, an Alzheimer’s drug.